Data dictionary: Gynecological oncology - DGOA: Difference between revisions
From Beacon
(Created page with "Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page. This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. '''Healthcare Facility Information''' * Health Care Institution * Unique Patient Number '''Patient Demographics''' * Date of Birth * Gender * Date of Death (if applicable) '''Medical History & Comorbidities...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forresearchers}} | |||
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | ||
This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. | This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. | ||
'''Healthcare Facility Information | '''Table 1:''' Healthcare Facility Information. | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Health Care Institution | |||
|- | |||
| Unique Patient Number | |||
|} | |||
'''Table 2:''' Patient Demographics. | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date of Birth | |||
|- | |||
| Gender | |||
|- | |||
| Date of Death (if applicable) | |||
|} | |||
''' | '''Table 3:''' Medical History & Comorbidities. | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date Comorbidities Were Determined | |||
|- | |||
| Previous Comorbidities | |||
|- | |||
| Myocardial Infarction | |||
|- | |||
| Congestive Heart Failure | |||
|- | |||
| Peripheral Vascular Disease/Aortic Aneurysm | |||
|- | |||
| Cerebrovascular Disease (e.g., Stroke/TIA) | |||
|- | |||
| Dementia | |||
|- | |||
| Chronic Lung Disease | |||
|- | |||
| Connective Tissue Disease (e.g., Rheumatic Diseases) | |||
|- | |||
| Gastrointestinal Ulcer Disease | |||
|- | |||
| Liver Disease | |||
|- | |||
| Diabetes Mellitus | |||
|- | |||
| Paralysis/Hemiplegia | |||
|- | |||
| Kidney Disease | |||
|- | |||
| Malignancy (excluding PCC or BCC of the skin) | |||
|- | |||
| HIV/AIDS | |||
|- | |||
| Thrombosis/Pulmonary Embolism | |||
|- | |||
| Hypertension | |||
|} | |||
'''Table 4:''' Gynecological Information | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date of First Presentation to Gynecologist | |||
|- | |||
| Menopausal Status | |||
|- | |||
| Pregnancy at Diagnosis | |||
|- | |||
| Fertility Preservation Considered in Treatment? | |||
|} | |||
''' | '''Table 5:''' Surgical and Treatment Information | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date of Surgery | |||
|- | |||
| Patient Discussed in a Multidisciplinary Team | |||
|- | |||
| Patient Discussed in a Postoperative Multidisciplinary Team | |||
|- | |||
| Treatment Undertaken or Reason for No Treatment | |||
|- | |||
| Type of Tumor for Current Registration | |||
|- | |||
| Participation in a Study | |||
|- | |||
| FIGO (2018) Classification - Overall | |||
|} | |||
'''Table 6:''' Pathological Analysis | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date Material Sent for Pathological Analysis | |||
|- | |||
| PA Laboratory | |||
|- | |||
| PA Number (TJJ-CCCCCC) for Preoperative Diagnosis | |||
|- | |||
| Method of Material Collection for PA | |||
|- | |||
| Histological Type of Tumor | |||
|- | |||
| Largest Tumor Size Outside Pelvis | |||
|- | |||
| Ovarian Removal Status (Unilateral/Bilateral) | |||
|- | |||
| Capsule Status | |||
|- | |||
| Total Number of Lymph Nodes | |||
|- | |||
| Total Number of Positive Lymph Nodes | |||
|} | |||
''' | '''Table 7:''' Complications and Follow-up | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Complications within 30 Days of Resection | |||
|- | |||
| Hospital Readmission within 30 Days of Discharge | |||
|- | |||
| Infections, Injuries, Wound Defects, Bleeding, Thrombosis, Functional Disorders, Systemic, Technical, Lymphedema/Lymphocele? | |||
|- | |||
| Type of Infection, Injury, Wound Defect, Bleeding, Thrombosis, Functional Disorder, Systemic Complication, Technical Complication | |||
|- | |||
| Date of Reintervention | |||
|- | |||
| Reintervention under General Anesthesia? | |||
|} | |||
'''Table 8:''' Chemotherapy and Radiotherapy | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Intent of Chemotherapy | |||
|- | |||
| Start Date of Chemotherapy | |||
|- | |||
| Location of Chemotherapy | |||
|- | |||
| Total Number of Cycles (Neoadjuvant and/or Adjuvant) | |||
|- | |||
| Radiotherapy Date | |||
|- | |||
| Type of Radiotherapy | |||
|- | |||
| Location of Radiotherapy | |||
|} | |||
''' | '''Table 9:''' Follow-up Information | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date of Most Recent Contact | |||
|- | |||
| Date of Start of Episode for Which This Follow-Up Is Entered | |||
|- | |||
| Recurrence? | |||
|- | |||
| Date of First Recurrence | |||
|- | |||
| Treatment for Recurrence (Surgery, Radiotherapy, Chemotherapy, Other Systemic Therapy) | |||
|} | |||
'''Table 10:''' COVID-19 Related Information | |||
''' | {| class="wikitable" | ||
! Variables | |||
|- | |||
| Suspicion or Test for SARS-CoV-2 Infection Before Admission to 30 Days After Discharge | |||
|- | |||
| Date of First Suspicion of SARS-CoV-2 Infection | |||
|- | |||
| Date of First Specific Test for SARS-CoV-2 Infection | |||
|- | |||
| Date of First Positive Lab Test for SARS-CoV-2 | |||
|- | |||
| ICU Admission and Discharge Dates and Times | |||
|- | |||
| Final Status Regarding SARS-CoV-2 | |||
|} | |||
Revision as of 13:48, 25 May 2024
Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.
This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.
Table 1: Healthcare Facility Information.
| Variables |
|---|
| Health Care Institution |
| Unique Patient Number |
Table 2: Patient Demographics.
| Variables |
|---|
| Date of Birth |
| Gender |
| Date of Death (if applicable) |
Table 3: Medical History & Comorbidities.
| Variables |
|---|
| Date Comorbidities Were Determined |
| Previous Comorbidities |
| Myocardial Infarction |
| Congestive Heart Failure |
| Peripheral Vascular Disease/Aortic Aneurysm |
| Cerebrovascular Disease (e.g., Stroke/TIA) |
| Dementia |
| Chronic Lung Disease |
| Connective Tissue Disease (e.g., Rheumatic Diseases) |
| Gastrointestinal Ulcer Disease |
| Liver Disease |
| Diabetes Mellitus |
| Paralysis/Hemiplegia |
| Kidney Disease |
| Malignancy (excluding PCC or BCC of the skin) |
| HIV/AIDS |
| Thrombosis/Pulmonary Embolism |
| Hypertension |
Table 4: Gynecological Information
| Variables |
|---|
| Date of First Presentation to Gynecologist |
| Menopausal Status |
| Pregnancy at Diagnosis |
| Fertility Preservation Considered in Treatment? |
Table 5: Surgical and Treatment Information
| Variables |
|---|
| Date of Surgery |
| Patient Discussed in a Multidisciplinary Team |
| Patient Discussed in a Postoperative Multidisciplinary Team |
| Treatment Undertaken or Reason for No Treatment |
| Type of Tumor for Current Registration |
| Participation in a Study |
| FIGO (2018) Classification - Overall |
Table 6: Pathological Analysis
| Variables |
|---|
| Date Material Sent for Pathological Analysis |
| PA Laboratory |
| PA Number (TJJ-CCCCCC) for Preoperative Diagnosis |
| Method of Material Collection for PA |
| Histological Type of Tumor |
| Largest Tumor Size Outside Pelvis |
| Ovarian Removal Status (Unilateral/Bilateral) |
| Capsule Status |
| Total Number of Lymph Nodes |
| Total Number of Positive Lymph Nodes |
Table 7: Complications and Follow-up
| Variables |
|---|
| Complications within 30 Days of Resection |
| Hospital Readmission within 30 Days of Discharge |
| Infections, Injuries, Wound Defects, Bleeding, Thrombosis, Functional Disorders, Systemic, Technical, Lymphedema/Lymphocele? |
| Type of Infection, Injury, Wound Defect, Bleeding, Thrombosis, Functional Disorder, Systemic Complication, Technical Complication |
| Date of Reintervention |
| Reintervention under General Anesthesia? |
Table 8: Chemotherapy and Radiotherapy
| Variables |
|---|
| Intent of Chemotherapy |
| Start Date of Chemotherapy |
| Location of Chemotherapy |
| Total Number of Cycles (Neoadjuvant and/or Adjuvant) |
| Radiotherapy Date |
| Type of Radiotherapy |
| Location of Radiotherapy |
Table 9: Follow-up Information
| Variables |
|---|
| Date of Most Recent Contact |
| Date of Start of Episode for Which This Follow-Up Is Entered |
| Recurrence? |
| Date of First Recurrence |
| Treatment for Recurrence (Surgery, Radiotherapy, Chemotherapy, Other Systemic Therapy) |
Table 10: COVID-19 Related Information
| Variables |
|---|
| Suspicion or Test for SARS-CoV-2 Infection Before Admission to 30 Days After Discharge |
| Date of First Suspicion of SARS-CoV-2 Infection |
| Date of First Specific Test for SARS-CoV-2 Infection |
| Date of First Positive Lab Test for SARS-CoV-2 |
| ICU Admission and Discharge Dates and Times |
| Final Status Regarding SARS-CoV-2 |